top of page
LAA Patient Living Life

A Clinical Trial
for Patients with
Non-valvular Atrial Fibrillation 

NOW ENROLLING

The FDA approved CONFORM Pivotal Trial is evaluating the CLAAS® AcuFORM™ Implant compared to other commercially available Left Atrial Appendage Occlusion (LAAO) devices in patients with non-valvular Atrial Fibrillation (AFib).

A New Device for Treating the Left Atrial Appendage (LAA)

The CLAAS AcuFORM Implant is a foam device designed to conform to patient anatomy and seal the LAA to reduce the risk of blood clots causing strokes without the need for anticoagulants. The implant is permanently placed in the heart by your physician during a single minimally invasive procedure.

Participating in
A Clinical Trial

Participating in a clinical trial offers access to innovative treatments, comprehensive care, and the opportunity to actively contribute to personal health and medical advancements. It helps improve future therapies, often covers costs, and provides a supportive environment.

 

While risks exist, participants play a vital role in shaping the future of medicine.

dotted background.png

Find a CONFORM Trial site near you.

CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.

  • LinkedIn
  • Facebook

©2025 Conformal Medical, Inc. All rights reserved. Conformal, CLAAS, and The Shape of Stroke Prevention are registered trademarks and AcuFORM is a trademark of Conformal Medical, Inc

​

MC-46 v.1

bottom of page